Today: 16 May 2026
Browse Category

Earnings Reports 28 January 2026 - 29 January 2026

IBM stock price jumps after hours as Q4 results lift AI and 2026 outlook

IBM stock price jumps after hours as Q4 results lift AI and 2026 outlook

IBM shares rose 7.8% to $317 in after-hours trading Wednesday after reporting fourth-quarter revenue of $19.7 billion, up 12%. The company projected over 5% revenue growth for 2026 in constant currency and expects about $1 billion more in free cash flow. Red Hat growth slowed to 10%, partly due to a late-2025 U.S. government shutdown. IBM’s $11 billion Confluent acquisition is set to close by mid-2026.
Dow Jones closes flat after Fed; Microsoft drops, IBM jumps in after-hours ahead of Apple earnings

Dow Jones closes flat after Fed; Microsoft drops, IBM jumps in after-hours ahead of Apple earnings

Microsoft fell nearly 4% after hours as AI capital spending jumped 66%. IBM rose 6% on strong revenue, Meta gained 4% after forecasting up to $135 billion in 2026 capex, and Tesla advanced 2% with a $2 billion xAI investment. The S&P 500 briefly topped 7,000. The Fed held rates steady at 3.50%-3.75%.
Tesla Q4 Earnings: Revenue Beats, Profit Sinks, and Musk’s xAI Bet Moves to Center Stage

Tesla Q4 Earnings: Revenue Beats, Profit Sinks, and Musk’s xAI Bet Moves to Center Stage

Tesla posted fourth-quarter revenue of $24.9 billion, beating forecasts, but net income plunged 61% to $840 million. The company confirmed a $2 billion investment in Elon Musk’s xAI and reported a 15.6% drop in vehicle deliveries. Automotive sales fell 11%, while energy storage revenue jumped 25%. The stock was little changed after hours.
NextEra Energy stock price today: NEE steadies near a 52-week high as investors parse earnings, data-center demand

NextEra Energy stock price today: NEE steadies near a 52-week high as investors parse earnings, data-center demand

NextEra Energy shares rose 0.3% to $87.44 Wednesday afternoon after reporting 2025 adjusted earnings of $3.71 per share, up 8% from 2024. Executives said they are in advanced talks to supply 9 GW of data-center power in Florida and plan to add 6 GW of new nuclear capacity. Trading volume topped 5.7 million shares. Mizuho raised its price target to $90.
Bloom Energy stock jumps nearly 10% as Barclays starts coverage ahead of earnings

Bloom Energy stock jumps nearly 10% as Barclays starts coverage ahead of earnings

Bloom Energy shares surged 9.6% to $166.94 Wednesday, with volume topping 10.7 million after Baird raised its price target and Barclays began coverage. The rally follows a $2.65 billion fuel-cell deal with American Electric Power. Investors await Bloom’s Feb. 5 earnings for updates on production capacity and data-center demand. Plug Power and FuelCell Energy also posted gains.
ServiceNow stock slips before earnings as Fed holds rates — what to watch in NOW shares

ServiceNow stock slips before earnings as Fed holds rates — what to watch in NOW shares

ServiceNow shares fell 1.2% to $130.24 Wednesday afternoon as investors awaited quarterly earnings due after the bell. Wall Street focused on subscription growth and backlog, with analysts expecting revenue of $3.53 billion, up 19% year-over-year. The Fed held rates steady, pressuring tech stocks. ServiceNow recently expanded its AI partnership with OpenAI.
Sandisk stock price jumps 8% as storage rally builds ahead of SNDK earnings

Sandisk stock price jumps 8% as storage rally builds ahead of SNDK earnings

Sandisk shares jumped 8.5% to $522.41 Wednesday as storage stocks surged after Seagate forecast stronger revenue on AI-driven data-center demand. Traders are positioning ahead of Sandisk’s fiscal Q2 results due Thursday. Sandisk has soared over 1,000% in six months, pushing its value to $69 billion. A new leveraged ETF tracking Sandisk also launched.
Starbucks stock swings after earnings pop — what investors watch at Niccol’s investor day

Starbucks stock swings after earnings pop — what investors watch at Niccol’s investor day

Starbucks shares rose 1% to $96.56 after swinging more than 10% following Q1 results showing 4% global same-store sales growth and first U.S. increase in two years. Margins fell for the eighth straight quarter, frustrating investors. CEO Brian Niccol cited new drinks as growth drivers but warned service targets will take time. All eyes turn to Thursday’s investor day for margin guidance.
28 January 2026
Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health shares jumped 6% to $343.14 Wednesday after the company set a 2026 profit floor despite warning of lower revenue. The move followed a $80 billion sector selloff triggered by new Medicare payment proposals. Elevance projected 2026 adjusted earnings of at least $25.50 per share and year-end enrollment up to 43.875 million. Fourth-quarter operating revenue reached $49.3 billion.
Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet shares jumped 11% to $58.65 by early afternoon Wednesday after quarterly earnings and a third-quarter forecast topped Wall Street estimates. The company reported fiscal Q2 sales of $6.319 billion and adjusted EPS of $1.05, beating analyst expectations. Arrow Electronics and TD SYNNEX also rose. Avnet projected Q3 sales of $6.20–$6.50 billion and adjusted EPS of $1.20–$1.30.
Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Pfizer shares fell 1.8% to $26.02 after U.S. Medicare included Xeljanz in its upcoming drug price negotiations, set to begin in 2026 with prices effective in 2028. The Centers for Medicare & Medicaid Services named 15 drugs for talks, and companies must decide by February 28 whether to participate. Investors are awaiting Pfizer’s February 3 earnings for updates on pricing risks.
Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

Mastercard shares slipped 0.1% to $519.71 by midday Wednesday, trailing Visa’s gains ahead of Thursday’s earnings report. The company unveiled a new AI-driven “Agent Suite” Tuesday, aiming for a Q2 2026 launch. Cantor Fitzgerald initiated coverage with an Overweight rating and a $650 price target. Mastercard stock remains about 13.5% below its 52-week high.
1 85 86 87 88 89 248

Stock Market Today

  • PVH Shares Drop 3% as April Inflation Surges to 3.8% Annual Rate
    May 15, 2026, 8:16 PM EDT. PVH shares fell 3% following the latest Consumer Price Index report showing inflation at a 3.8% annual rate in April, the fastest since 2023. Energy costs, notably a 5.4% rise in gasoline prices linked to the Iran conflict, sharply increased. Higher prices for essentials like food and shelter raised concerns over reduced consumer spending on discretionary items, impacting retail and consumer goods sectors. PVH's stock, volatile with 14 moves over 5% in the past year, reacted moderately compared to a recent 7.7% drop amid crude oil price surges and weak consumer sentiment. Goldman Sachs lowered its 2026 discretionary cash flow forecast from 5.1% to 3.7%, citing squeezed consumer budgets. PVH trades 18% below its 52-week high, with long-term investors facing a decline in value.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop